Trial intelligence / Profile preview

Remimazolam vs Propofol for Anesthesia Induction

NCT05635201Phase 3Completed

Sponsor
Daegu Catholic University Medical Center
Start
Dec 2022
Primary completion
Sep 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of remimazolam in general anesthesia, sponsored by Daegu Catholic University Medical Center. Started Dec 2022; status: completed.

02

Drugs

remimazolam
03

Conditions

general anesthesia

Beyond the preview

Go deeper on NCT05635201.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05635201.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call